International Journal of Clinical Case Reports 2024, Vol.14, No.2, 87-93 http://medscipublisher.com/index.php/ijccr 93 genetic testing in medicine, not only in drug therapy, but also in prevention, early screening, and chronic disease management. References Fu M., Tayebee R., Saberi S., Nourbakhsh N., Esmaeili E., Maleki B., and Vatanpour H.R., 2021, Studying adsorption and cellular toxicity of boron nitride nanostructure versus melphalan anti-ovarian cancer drug, Curr. Mol. Med., 21(8): 698-705. https://doi.org/10.2174/1566524021666210111104428 Li L.X., Zhang D., Liu B.L., Lü D.,Zhai J.T., Guan X.W., Yi Z.B., and Ma F., 2022, Antibody-drug conjugates in HER2-positive breast cancer, Chinese Med. J., 135(3): 261-267. https://doi.org/10.1097/CM9.0000000000001932 Li S.S., Wei D.D., and Jiang S.Q., 2021, Toxicity of chemotherapeutics based on viscera-state doctrine, Zhongguo Shiyan Fangjixue Zazhi (Chinese Journal of Experimental Traditional Medical Formulae), 27(5): 198-205. Li Z., Han C.M., Chen G.W., and Zhao H.W., 2022, Analysis of clinical phenotype and variant of SLC2A1 gene in a Chinese pedigree affected with glucose transporter 1 deficiency syndrome, Zhonghua Yixue Yichuanxue Zazhi (Chinese Journal of Medical Genetics), 39(8): 884-888. Liu Q.H., Huang Q.Y., Yu Z.K., and Wu H.M., 2022, Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions, Clin. Respir. J., 16(3): 216-225. https://doi.org/10.1111/crj.13472 Ma Z.K., Guo T.T., Wang Y., Wu T., Wang Y., Li K.X., Ou X.J., Jia J.D., and Zhao X.Y., 2023, Study on clinical characteristic difference of drug-induced liver injury between patients of different gender, Yaowu Buliang Fanying Zazhi (Adverse Drug Reactions Journal), 25(2): 69-75. Mikko N., Aleksi T., Paivi H., Janne T.B., and Mikko N., 2021, Performance of plasma coproporphyrin I and III as OATP1B1 biomarkers in humans, Clin. Pharmacol. Ther., 110(6): 1622-1632. https://doi.org/10.1002/cpt.2429 Prasanna P.L., Renu K., and Gopalakrishnan A.V., 2020, New molecular and biochemical insights of doxorubicin-induced hepatotoxicity, Life Sci., 250: 117599. https://doi.org/10.1016/j.lfs.2020.117599 Shunsuke G, Yukimi S., Keishi A., Yoshitaka S., Seiji Y., Masatoshi E., and Koji T., 2021, Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models, Cancer Immunol. Immun., 70(9): 2503-2515. https://doi.org/10.1007/s00262-021-02853-3 Sterner R.C., and Sterner R.M., 2021, CAR-T cell therapy: current limitations and potential strategies, Blood Cancer J., 11(4): 69. https://doi.org/10.1038/s41408-021-00459-7 Wang D.X., 2023, Research in warfarin anticoagulant treatment and genetic polymorphisms of CYP2C9, Yixue X (Medical Information), 36(2): 176-179. Zaki S.A., Helal M.E., and Rashid A., 2022, Cardiovascular toxicity due to otilonium bromide overdose: a case report, J. Emerg. Med., 62(3): e47-e50. https://doi.org/10.1016/j.jemermed.2021.10.025 Zhang J., Qian Z.Y., and Zhou D.M., 2020, Research progress of toxicity on the effects of pesticides on immune system, Zhiye yu Jiankang (Occupation and Health), 36(11): 1577-1580, 1584.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==